Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 196, Issue 9, Pages 3608-3617
Publisher
The American Association of Immunologists
Online
2016-03-26
DOI
10.4049/jimmunol.1502303
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The nature of self for T cells—a systems-level perspective
- (2015) Diana P Granados et al. CURRENT OPINION IN IMMUNOLOGY
- Quantifying epitope presentation using mass spectrometry
- (2015) Nathan P. Croft et al. MOLECULAR IMMUNOLOGY
- Discovery of a Small Non-AUG-Initiated ORF in Poleroviruses and Luteoviruses That Is Required for Long-Distance Movement
- (2015) Ekaterina Smirnova et al. PLoS Pathogens
- Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors
- (2014) L. C. Anton et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Enantioselective Total Syntheses of FR901464 and Spliceostatin A and Evaluation of Splicing Activity of Key Derivatives
- (2014) Arun K. Ghosh et al. JOURNAL OF ORGANIC CHEMISTRY
- The nature and extent of contributions by defective ribosome products to the HLA peptidome
- (2014) D. Bourdetsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conserved and host-specific features of influenza virion architecture
- (2014) Edward C. Hutchinson et al. Nature Communications
- Pathways of Antigen Processing
- (2013) Janice S. Blum et al. Annual Review of Immunology
- Most Influenza A Virions Fail To Express at Least One Essential Viral Protein
- (2013) C. B. Brooke et al. JOURNAL OF VIROLOGY
- Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins
- (2013) N. S. Heaton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinetics of Antigen Expression and Epitope Presentation during Virus Infection
- (2013) Nathan P. Croft et al. PLoS Pathogens
- Nuclear translation visualized by ribosome-bound nascent chain puromycylation
- (2012) Alexandre David et al. JOURNAL OF CELL BIOLOGY
- Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I
- (2012) S. R. Starck et al. SCIENCE
- An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response
- (2012) B. W. Jagger et al. SCIENCE
- Decoding Human Cytomegalovirus
- (2012) N. Stern-Ginossar et al. SCIENCE
- Identification of a Novel Splice Variant Form of the Influenza A Virus M2 Ion Channel with an Antigenically Distinct Ectodomain
- (2012) Helen M. Wise et al. PLoS Pathogens
- Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
- (2011) Nicholas T. Ingolia et al. CELL
- Non-conventional sources of peptides presented by MHC class I
- (2011) Shelley R. Starck et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overlapping signals for translational regulation and packaging of influenza A virus segment 2
- (2011) H. M. Wise et al. NUCLEIC ACIDS RESEARCH
- RNA Polymerase II Inhibitors Dissociate Antigenic Peptide Generation from Normal Viral Protein Synthesis: A Role for Nuclear Translation in Defective Ribosomal Product Synthesis?
- (2010) B. P. Dolan et al. JOURNAL OF IMMUNOLOGY
- Defective Ribosomal Products Are the Major Source of Antigenic Peptides Endogenously Generated from Influenza A Virus Neuraminidase
- (2009) B. P. Dolan et al. JOURNAL OF IMMUNOLOGY
- Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
- (2008) Tong-Ming Fu et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started